Sign in
4

Changes in Ownership

Eton Pharmaceuticals, Inc. Filed Acc 0001209191-19-018103

Options or other derivatives

  • President & CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRYNJELSEN SEAN · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-20 Grant or award : show line 1 in the form Stock option (right to buy) +250,000 250,000 D
Loading xslF345X03/doc4.xml…